Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · Real-Time Price · USD
1.140
+0.030 (2.70%)
Oct 2, 2026, 12:26 PM EDT - Market open
Dermata Therapeutics Market Cap
Dermata Therapeutics has a market cap or net worth of $4.59 million as of October 2, 2026. Its market cap has increased by 31.14% in one year.
Market Cap
4.59M
Enterprise Value
172.48K
1-Year Change
31.14%
Ranking
Category
Stock Price
$1.14
ChartMarket Cap Chart
Since the IPO on August 13, 2021, Dermata Therapeutics's market cap has decreased from $57.49M to $4.59M, a decrease of -92.02%. That is a compound annual growth rate of -38.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 4.59M | -25.70% |
| Dec 31, 2025 | 6.17M | 124.01% |
| Dec 31, 2024 | 2.76M | 27.62% |
| Dec 29, 2023 | 2.16M | -56.38% |
| Dec 30, 2022 | 4.95M | -65.85% |
| Dec 31, 2021 | 14.49M | -74.79% |
| Aug 13, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Liminatus Pharma | 5.41M |
| NuCana | 5.34M |
| Xenetic Biosciences | 5.32M |
| Ernexa Therapeutics | 5.12M |
| AIM ImmunoTech | 5.10M |
| Lexaria Bioscience | 5.10M |
| Can-Fite BioPharma | 4.75M |
| PharmaCyte Biotech | 4.50M |